申请人:Leadiant Biosciences SA
公开号:EP3381906A1
公开(公告)日:2018-10-03
The present invention relates to the use of compounds of formula [R - L1 - Ar1 - L - Ar]2- X having an anti-heparanase activity, in particular for the treatment of diseases and disorders associated with a heparanase activity.
本发明涉及具有抗肝素酶活性的式[R - L1 - Ar1 - L - Ar]2- X化合物的用途,特别是用于治疗与肝素酶活性相关的疾病和失调。